Researchers at Johns Hopkins School of Medicine have confirmed that mixing low-dose opioids with synthetic cannabis offers no added pain relief for osteoarthritis patients. This finding challenges common patient beliefs and clinical practices, revealing that the combination actually increases adverse side effects without reducing acute pain.
Lead author Katrina Hamilton, PhD, a Psychiatry Professor at Johns Hopkins, noted that while some clinicians prescribe this combination in states where cannabis is legal, the clinical data does not support its efficacy for pain management.
The small trial involved 21 patients with knee osteoarthritis who were tested under four conditions: placebo, hydromorphone alone, dronabinol alone, and a combination of both. However, several critical caveats limit the study’s real-world applicability:
- Acute vs. Chronic Pain: The study measured acute pain induced by cold water and “hot” capsaicin cream in a laboratory setting, rather than the actual chronic joint pain caused by arthritis.
- Synthetic vs. Natural Cannabis: Dronabinol (Marinol) is an FDA-approved synthetic THC meant for nausea and appetite stimulation, not pain relief. It differs vastly from the natural cannabis forms (edibles, smoking, vaping) used by real-world consumers.
- Low Opioid Dosage: The 2mg oral dose of hydromorphone (about 10 morphine milligram equivalents) was relatively low, which researchers admit produces little pain relief on its own.
Despite the low opioid dose, the study utilized a hefty 10mg dose of dronabinol. Interestingly, participants reported a stronger “high” sensation from the synthetic cannabis than from the opioid.
Ultimately, the opioid alone slightly reduced pain sensitivity, while dronabinol did not. When combined, they failed to meaningfully reduce self-reported pain, instead worsening drowsiness and cognitive impairment.
Hamilton acknowledged these limitations, emphasizing that real-world cannabis users often employ different dosing strategies, such as starting low and gradually increasing strength. “More research is needed to better understand how cannabis affects pain when used in real-world settings,” she concluded.